- Home
- DBVT vs ONDS Comparison
DBVT vs ONDS Comparison
Compare DBVT & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBVT
- ONDS
- Stock Information
- Founded
- DBVT 2002
- ONDS 2014
- Country
- DBVT France
- ONDS United States
- Employees
- DBVT N/A
- ONDS N/A
- Industry
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- ONDS Telecommunications Equipment
- Sector
- DBVT Health Care
- ONDS Telecommunications
- Exchange
- DBVT Nasdaq
- ONDS Nasdaq
- Market Cap
- DBVT 237.4M
- ONDS 326.8M
- IPO Year
- DBVT N/A
- ONDS N/A
- Fundamental
- Price
- DBVT N/A
- ONDS $1.87
- Analyst Decision
- DBVT Buy
- ONDS Strong Buy
- Analyst Count
- DBVT 4
- ONDS 2
- Target Price
- DBVT $14.81
- ONDS $3.25
- AVG Volume (30 Days)
- DBVT 31.5K
- ONDS 23.4M
- Earning Date
- DBVT 07-29-2025
- ONDS 08-13-2025
- Dividend Yield
- DBVT N/A
- ONDS N/A
- EPS Growth
- DBVT N/A
- ONDS N/A
- EPS
- DBVT N/A
- ONDS N/A
- Revenue
- DBVT $3,497,000.00
- ONDS $10,815,867.00
- Revenue This Year
- DBVT $1,700.53
- ONDS $243.35
- Revenue Next Year
- DBVT $535.67
- ONDS $113.88
- P/E Ratio
- DBVT N/A
- ONDS N/A
- Revenue Growth
- DBVT N/A
- ONDS N/A
- 52 Week Low
- DBVT $2.21
- ONDS $0.54
- 52 Week High
- DBVT $12.78
- ONDS $3.40
- Technical
- Relative Strength Index (RSI)
- DBVT 66.88
- ONDS 66.06
- Support Level
- DBVT $9.13
- ONDS $1.53
- Resistance Level
- DBVT $10.80
- ONDS $2.29
- Average True Range (ATR)
- DBVT 0.78
- ONDS 0.20
- MACD
- DBVT 0.23
- ONDS 0.01
- Stochastic Oscillator
- DBVT 88.83
- ONDS 63.98
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.